<p>A: CDDP (0–10 µM, 24 h) induced apoptosis in chemo-sensitive OV2008 and A2780s but not their resistant counterparts C13* and A2780cp, whereas SB225002 (0–1000 nM, 24 h) induced apoptosis in all cell lines. The OVCAs were treated with different concentration of SB225002 or of CDDP for 24 h. The attached (viable) and floating (apoptotic) cells were pooled, washed and resuspended in neutral-buffered formalin (4%) containing Hoechst 33258 dye (3.75 ng/ml, 24 h). The percentage of apoptosis was determined based on nuclear morphology. At least 400 cells were counted in each group and the counter “blinded” to sample identity to avoid experimental bias. B: SB225002 induced caspase 3 activation and PARP cleavage (Western blot) in all OVCA cells e...
<p>(A) Cells incubated with 10 µM of polyfosine or edelfosine for indicated times were fixed and pro...
BACKGROUND: To study the apoptotic process in time, we used the following flow cytometric (FCM) tech...
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...
Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist...
Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist...
<div><p>Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its an...
<p>(A) All nine OCCA cells were treated with DS-7423 at 156 or 2,560 nM for 48 h, and apoptotic cell...
<p>A: SB225002 (0–1000 nM, 24 h) increased total- and phospho-p53 (S15) level in OV2008, C13*, A2780...
<p>(A) A2780 and OV2008 cells were treated with PMBPs (0, 25, 50, 100 μg/ml) for 24 h. The morpholog...
<p>(<b>A</b>) OEC-M1 cells were treated with 0.25 or 0.5 μM of MPT0B098 for 12 hrs. Cells were then ...
<p>A: SB225002 (0–1000 nM, 24 h) induced apoptosis in SKOV3 cells (upper). B: SB225002 increased SKO...
<p>A: SB225002 (0–1000 nM, 24 h) decreased total and phospho-Chk1 (S317 and S345) levels in OV2008 c...
<p>Effect of SB225002 [100 to 1.5625 μM] on the survival and proliferation of <b>(A)</b> B-ALL and T...
<p>(<b>A</b>) Cells were seeded in 96-well plates, treated with compound <b>1a</b> (1.25 ∼ 40 µM) or...
<p>A, OCCC cell lines were treated with 1 µM ABT-737 (A), 1 µM BEZ235 (B), or 5 µM PF271 (P), indivi...
<p>(A) Cells incubated with 10 µM of polyfosine or edelfosine for indicated times were fixed and pro...
BACKGROUND: To study the apoptotic process in time, we used the following flow cytometric (FCM) tech...
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...
Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist...
Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist...
<div><p>Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its an...
<p>(A) All nine OCCA cells were treated with DS-7423 at 156 or 2,560 nM for 48 h, and apoptotic cell...
<p>A: SB225002 (0–1000 nM, 24 h) increased total- and phospho-p53 (S15) level in OV2008, C13*, A2780...
<p>(A) A2780 and OV2008 cells were treated with PMBPs (0, 25, 50, 100 μg/ml) for 24 h. The morpholog...
<p>(<b>A</b>) OEC-M1 cells were treated with 0.25 or 0.5 μM of MPT0B098 for 12 hrs. Cells were then ...
<p>A: SB225002 (0–1000 nM, 24 h) induced apoptosis in SKOV3 cells (upper). B: SB225002 increased SKO...
<p>A: SB225002 (0–1000 nM, 24 h) decreased total and phospho-Chk1 (S317 and S345) levels in OV2008 c...
<p>Effect of SB225002 [100 to 1.5625 μM] on the survival and proliferation of <b>(A)</b> B-ALL and T...
<p>(<b>A</b>) Cells were seeded in 96-well plates, treated with compound <b>1a</b> (1.25 ∼ 40 µM) or...
<p>A, OCCC cell lines were treated with 1 µM ABT-737 (A), 1 µM BEZ235 (B), or 5 µM PF271 (P), indivi...
<p>(A) Cells incubated with 10 µM of polyfosine or edelfosine for indicated times were fixed and pro...
BACKGROUND: To study the apoptotic process in time, we used the following flow cytometric (FCM) tech...
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...